Trial intelligence / Profile preview

Hylo-Dual vs Olopatadine in Pediatric Seasonal Allergic Conjunctivitis

NCT03186755Phase 4Unknown

Start
Jun 2017
Primary completion
Dec 2024
Countries
1
01

Overview

A Phase 4 trial of ectoine + hyaluronic acid in seasonal allergic conjunctivitis (SAC). Status: unknown.

02

Drugs

ectoine + hyaluronic acid
03

Conditions

seasonal allergic conjunctivitis (SAC)

Beyond the preview

Go deeper on NCT03186755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03186755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call